Disclosure Of Entity's Operating Segments [Text Block]

Tchaikapharma High Quality Medicines AD - Filing #6023728

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Disclosure of entity's operating segments [text block]
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue
48 512 BGN
43 146 BGN
Depreciation and amortisation expense
2 809 BGN
3 568 BGN
Tax expense (income)
470,000 BGN
342,000 BGN
Profit (loss) before tax
3 868 BGN
3 132 BGN
Profit (loss)
- BGN
- BGN
3 398 BGN
- BGN
- BGN
3 398 BGN
3 398 BGN
- BGN
- BGN
2 790 BGN
- BGN
2 790 BGN
2 790 BGN
- BGN
Assets
122 499 BGN
119 861 BGN
Liabilities
17 498 BGN
18 276 BGN
Cash flows from (used in) operating activities
2 864 BGN
2 461 BGN
Cash flows from (used in) investing activities
1 912 BGN
1 580 BGN
Cash flows from (used in) financing activities
1 021 BGN
796,000 BGN
Disclosure of products and services [text block]
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]
Disclosure of major customers [abstract]
Disclosure of major customers [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.